Evidence map›Paper›PMID 34999370›Full record

ArticleJournal of psychiatric research2022

Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence.

Chun S Zuo, Katherine A Davis, Madeline K Kuppe, M Kathryn Dahlgren, Staci Gruber, Garrett M Fitzmaurice, Scott E Lukas

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Chronic cannabis use alters dACC-striatal glutamatergic balance.Pharmacology, biochemistry, and behavior · 2023
    Article
  5. Lower dACC glutamate in cannabis users during early phase abstinence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chun S ZuoMcLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA. Electronic address: chun@mclean.harvard.edu.
Katherine A DavisMcLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Madeline K KuppeCognitive and Clinical Neuroimaging Core, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
M Kathryn DahlgrenCognitive and Clinical Neuroimaging Core, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Staci GruberCognitive and Clinical Neuroimaging Core, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Garrett M FitzmauriceLaboratory for Psychiatric Biostatistics, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Scott E LukasMcLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Harvard University · US

Funding

Brain Neurochemical Profile During Marijuana AbstinenceR21DA041574 · NIDA · MCLEAN HOSPITAL · PI ZUO, CHUN S · 2017 to 2018
$449k
NIDA NIH HHS R21 DA041574
6 · The paper itself

Abstract

Cannabis withdrawal symptoms contribute to relapse, but the underlying mechanism remains unclear. We hypothesize that cannabis withdrawal may be associated with a reset of regional γ-amino butyric acid (GABA) and glutamate concentrations secondary to changes in the endocannabinoid system during abstinence and conducted a study on this issue. We used magnetic resonance spectroscopy (MRS) to detect the associated changes of these neurochemicals in twenty-six frequent, recreational cannabis users and eleven age-matched non-using controls. Twenty users (8F/12M) and ten control (5F/5M) participants completed a verified 21-day abstinence period. Striatal GABA and glutamine concentrations were measured at baseline and on abstinence days 7 and 21 in conjunction with measures of cannabis withdrawal symptoms and mood state. Cannabis users reported increased self-reported ratings of cannabis-withdrawal-symptoms on abstinence day 7 relative to controls. Striatal glutamate + glutamine (Glx) group concentrations were elevated in cannabis users at baseline and abstinence days 7 and 21 (F = 7.16, p = 0.012), and changes in GABA concentration and withdrawal symptoms between baseline and abstinence day 7 were positively correlated (r = 0.550, p = 0.010). In addition, baseline striatal GABA concentrations were negatively correlated with withdrawal symptoms on abstinence day 7 (r = -0.680, p = 0.003). Our data demonstrate that striatal Glx was elevated in cannabis users and baseline striatal GABA correlated with withdrawal during the abstinence. In addition, striatal GABA may temporally correlate with self-reported withdrawal symptoms during the initial days of abrupt cannabis abstinence. These findings provide preliminary evidence that striatal GABA and Glx are associated with the severity of cannabis withdrawal.

Indexed as

CannabisHallucinogensSubstance Withdrawal Syndromegamma-Aminobutyric AcidGlutamic AcidGlutamineHumansgamma-Aminobutyric AcidGlutamic AcidGlutamineHallucinogensAssociationCannabisGABAGlutamateStriatalWithdrawal

Identifiers

PMID34999370
PMCPMC8803139
OpenAlexW4200046076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.